To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TSTD2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
305 supporting clones for gene TSTD2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA735730   TSTD2.a 1 to 811 2 to 814   tiling clone, capped   813/815
(99 %)
9 diff
(98.9 %id)
DB368063   TSTD2.a 1936 to 2474 537 to 1   tiling clone,   537/541
(99 %)
12 diff
(97.8 %id)
BE676165 B-cell, chronic lymphotic leukemia TSTD2.b 1 to 460 460 to 1   tiling clone,   460/460
(100 %)
2 diff
(99.6 %id)
NM_139246.4   TSTD2.b 289 to 4715 1 to 4427 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 4427/4427
(100 %)
0 diff
(100 %id)
CN298691 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TSTD2.b 426 to 1056 1 to 632   tiling clone,   632/632
(100 %)
1 diff
(99.9 %id)
DB097994 testis TSTD2.b 449 to 1044 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
TI_157605959   TSTD2.b 467 to 1122 58 to 715     Submitted on the opposite strand 658/976
(67 %)
20 diff
(98.0 %id)
AW451910   TSTD2.b 472 to 927 1 to 456     Submitted on the opposite strand 456/456
(100 %)
2 diff
(99.6 %id)
DA228507 brain TSTD2.b 483 to 1040 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AA252711 germinal center B cell TSTD2.b 531 to 910 1 to 379     Submitted on the opposite strand 379/379
(100 %)
1 diff
(99.8 %id)
BU848823 ovary, teratocarcinoma, cell line TSTD2.b 582 to 1486 1 to 911       911/925
(98 %)
9 diff
(99.1 %id)
DA322748 hippocampus TSTD2.b 583 to 1148 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA396899 thalamus TSTD2.b 589 to 1181 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA317361 hippocampus TSTD2.b 590 to 1159 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA800320 brain TSTD2.b 602 to 1178 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DA405096 thalamus TSTD2.b 605 to 1147 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB194640 trachea TSTD2.b 605 to 1170 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA224329 brain TSTD2.b 607 to 1252 2 to 647   capped   646/646
(100 %)
0 diff
(100 %id)
DB099963 testis TSTD2.b 607 to 1190 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA337784 hippocampus TSTD2.b 611 to 1190 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB071262 testis TSTD2.b 611 to 1155 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA215918 brain TSTD2.b 612 to 1072 2 to 464   capped   463/463
(100 %)
2 diff
(99.6 %id)
DA722732   TSTD2.b 612 to 1179 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA726394   TSTD2.b 612 to 1167 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA806038 brain TSTD2.b 612 to 1181 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA993777 synovial membrane tissue from rheumatioidarthritis TSTD2.b 612 to 1150 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA318095 hippocampus TSTD2.b 613 to 1170 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA802162 brain TSTD2.b 613 to 1171 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA806220 brain TSTD2.b 621 to 1187 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AK128615 trachea TSTD2.b 623 to 4709 1 to 4087 L30F S433C tiling clone, available from FLJ,   4087/4087
(100 %)
5 diff
(99.9 %id)
DA219666 brain TSTD2.b 624 to 1182 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB232404 trachea TSTD2.b 624 to 1223 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
CA390087 eye, RPE/choroid TSTD2.b 630 to 1169 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
DA326028 hippocampus TSTD2.b 631 to 1188 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AL525213 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized TSTD2.b 631 to 1559 1 to 929       929/929
(100 %)
1 diff
(99.9 %id)
DW446877 Liver TSTD2.b 634 to 839 9 to 215       207/215
(96 %)
10 diff
(95.4 %id)
BI460229 testis TSTD2.b 638 to 1170 1 to 535       535/535
(100 %)
11 diff
(98.0 %id)
DA334352 hippocampus TSTD2.b 642 to 1232 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
DB445373.
matches multiple genes
testis TSTD2.b 643 to 1077 1 to 435     also hits gene TMOD1 435/435
(100 %)
5 diff
(98.9 %id)
DA325806 hippocampus TSTD2.b 644 to 1203 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA738664   TSTD2.b 644 to 1214 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA797385 brain TSTD2.b 644 to 1190 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA798494 brain TSTD2.b 644 to 1150 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
DA807236 brain TSTD2.b 644 to 1190 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA809456 brain TSTD2.b 644 to 1243 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
DB144547 thymus TSTD2.b 644 to 1188 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB275719 uterus TSTD2.b 644 to 1209 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB284654 uterus TSTD2.b 644 to 1189 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DB290872 uterus TSTD2.b 644 to 1219 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA319264 hippocampus TSTD2.b 645 to 1220 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DR761640 embryonic stem TSTD2.b 646 to 1255 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
DA786512 brain TSTD2.b 646 to 1134 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
AI263217 Kidney TSTD2.b 648 to 910 263 to 1       263/272
(96 %)
0 diff
(100 %id)
BX538308 human uterus TSTD2.b 649 to 4715 1 to 4069 E73* available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 4069/4070
(99 %)
6 diff
(99.9 %id)
BX648493 human endometrium carcinoma cell line TSTD2.b 650 to 4709 1 to 4060 F72V A109D C432S available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 4060/4060
(100 %)
5 diff
(99.9 %id)
DA406629 thalamus TSTD2.b 651 to 1219 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA509810 brain TSTD2.b 651 to 1231 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DA798180 brain TSTD2.b 651 to 1203 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BC035604 Lymph, lymphoma TSTD2.b 652 to 4709 11 to 4068 R83Q available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 4058/4058
(100 %)
3 diff
(100.0 %id)
BG107185 lymph, lymphoma, cell line TSTD2.b 654 to 1383 1 to 731       731/731
(100 %)
21 diff
(97.2 %id)
DB073458 testis TSTD2.b 663 to 1203 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA807567 brain TSTD2.b 665 to 1202 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA800649 brain TSTD2.b 666 to 1212 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA460786 tongue, tumor tissue TSTD2.b 667 to 1190 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA496886 brain TSTD2.b 667 to 1226 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
AK291199   TSTD2.b 668 to 2730 1 to 2063 R83Q     2063/2063
(100 %)
3 diff
(99.9 %id)
DA313062 hippocampus TSTD2.b 669 to 1207 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA337938 hippocampus TSTD2.b 669 to 1245 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA754437   TSTD2.b 669 to 1197 2 to 531   capped   530/530
(100 %)
4 diff
(99.3 %id)
DA808349 brain TSTD2.b 669 to 1247 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB216011 trachea TSTD2.b 669 to 1219 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB237397 trachea TSTD2.b 669 to 1234 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB285276 uterus TSTD2.b 669 to 1223 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CN298694 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 TSTD2.b 670 to 1402 1 to 733       733/733
(100 %)
0 diff
(100 %id)
DA433829 tongue, tumor tissue TSTD2.b 673 to 1244 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB225407 trachea TSTD2.b 676 to 1236 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BG004073 placenta_normal TSTD2.b 689 to 1100 1 to 413       413/424
(97 %)
8 diff
(98.2 %id)
CN298692 embryonic stem cells, cell lines H1, H7, andH9 TSTD2.b 691 to 1323 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
CN298690 embryonic stem cells, cell lines H1, H7, andH9 TSTD2.b 735 to 1312 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BQ130825 insulinoma, Pancreas TSTD2.b 737 to 920 1 to 184   fully sequenced,   184/184
(100 %)
6 diff
(96.8 %id)
CA407697 adipose TSTD2.b 749 to 1371 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
DA490351 brain TSTD2.b 767 to 1333 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BQ130571 insulinoma, Pancreas TSTD2.b 783 to 924 142 to 1   fully sequenced,   142/142
(100 %)
5 diff
(96.5 %id)
CV030599 mixed TSTD2.b 858 to 1500 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
TI_1948133252   TSTD2.b 858 to 1697 135 to 976       842/1392
(60 %)
30 diff
(97.9 %id)
TI_1948133253   TSTD2.b 858 to 1610 140 to 895       756/1500
(50 %)
15 diff
(99.0 %id)
TI_1948133254   TSTD2.b 858 to 1609 133 to 890       758/1240
(61 %)
18 diff
(98.6 %id)
TI_1948133790   TSTD2.b 858 to 1822 137 to 1109       973/1427
(68 %)
57 diff
(96.1 %id)
TI_1948133791   TSTD2.b 858 to 1731 140 to 1014       875/1373
(63 %)
29 diff
(97.9 %id)
TI_1948133792   TSTD2.b 858 to 1612 134 to 889       756/1187
(63 %)
14 diff
(98.9 %id)
TI_1948134334   TSTD2.b 858 to 1728 126 to 1002       877/1411
(62 %)
22 diff
(98.5 %id)
TI_1948134335   TSTD2.b 858 to 1615 135 to 890       756/1399
(54 %)
20 diff
(98.6 %id)
TI_1948134336   TSTD2.b 858 to 1612 131 to 894       764/1289
(59 %)
24 diff
(98.2 %id)
TI_1948134869   TSTD2.b 858 to 1731 133 to 1007       875/1433
(61 %)
26 diff
(98.2 %id)
TI_1948134870   TSTD2.b 858 to 1612 138 to 894       757/1479
(51 %)
15 diff
(99.0 %id)
TI_1948134871   TSTD2.b 858 to 1615 133 to 891       759/1171
(64 %)
18 diff
(98.5 %id)
BG282137 melanotic melanoma, skin TSTD2.b 889 to 1652 1 to 764       764/764
(100 %)
21 diff
(97.3 %id)
BP356657 mammary gland TSTD2.b 1043 to 1627 1 to 585       585/587
(99 %)
4 diff
(99.4 %id)
DA786449 brain TSTD2.b 1088 to 1384 2 to 298   capped   297/297
(100 %)
1 diff
(99.7 %id)
BU662092 blood TSTD2.b 1098 to 1729 1 to 632       632/632
(100 %)
2 diff
(99.7 %id)
DA309117 hippocampus TSTD2.b 1113 to 1696 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DR001891 fetal brain TSTD2.b 1113 to 1780 9 to 674       666/674
(98 %)
9 diff
(98.7 %id)
CN298688 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TSTD2.b 1141 to 1744 1 to 604       604/604
(100 %)
0 diff
(100 %id)
AK056453   TSTD2.b 1162 to 4709 1 to 3548   available from FLJ,   3548/3548
(100 %)
4 diff
(99.9 %id)
DA740848   TSTD2.b 1163 to 1684 2 to 524   capped   523/525
(99 %)
2 diff
(99.7 %id)
DA721801   TSTD2.b 1173 to 1647 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
BQ302791 breast TSTD2.b 1180 to 1722 544 to 1       544/544
(100 %)
2 diff
(99.7 %id)
DA800476 brain TSTD2.b 1183 to 1684 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
CN298689 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 TSTD2.b 1212 to 1782 1 to 571       571/571
(100 %)
0 diff
(100 %id)
TI_1948133255   TSTD2.b 1381 to 2325 1074 to 126       949/1227
(77 %)
18 diff
(98.6 %id)
TI_1948133256   TSTD2.b 1381 to 2325 1075 to 129       947/1292
(73 %)
21 diff
(98.4 %id)
TI_1948134337   TSTD2.b 1381 to 2330 1088 to 122       965/1265
(76 %)
27 diff
(97.9 %id)
TI_1948134338   TSTD2.b 1381 to 2330 1075 to 127       949/1280
(74 %)
12 diff
(99.1 %id)
DA124093 cerebellum TSTD2.b 1396 to 1954 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
TI_1948134873   TSTD2.b 1416 to 2330 1043 to 121       923/1387
(66 %)
49 diff
(96.5 %id)
DA854207 placenta TSTD2.b 1443 to 2034 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BE784717 large cell carcinoma, lung TSTD2.b 1476 to 2195 1 to 710       708/913
(77 %)
43 diff
(95.3 %id)
DA858214 placenta TSTD2.b 1500 to 2070 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA190298 amygdala TSTD2.b 1504 to 2078 8 to 581   capped   574/580
(98 %)
7 diff
(98.8 %id)
TI_1948134872   TSTD2.b 1504 to 2330 950 to 121       830/1244
(66 %)
22 diff
(98.3 %id)
BE082506 breast TSTD2.b 1529 to 1722 195 to 1     Submitted on the opposite strand 195/198
(98 %)
3 diff
(98.5 %id)
TI_1948134339   TSTD2.b 1529 to 2330 934 to 120       815/1258
(64 %)
16 diff
(98.8 %id)
DA406783 thalamus TSTD2.b 1539 to 2102 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP251116 hippocampus TSTD2.b 1555 to 2136 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ344577 nervous_tumor TSTD2.b 1564 to 1898 10 to 345       336/345
(97 %)
2 diff
(99.5 %id)
CK327192 lung_tumor TSTD2.b 1571 to 2091 1 to 521       521/521
(100 %)
3 diff
(99.5 %id)
TI_1948133257   TSTD2.b 1611 to 2325 848 to 127       722/1223
(59 %)
8 diff
(99.4 %id)
TI_1948134874   TSTD2.b 1619 to 2330 837 to 120       718/1317
(54 %)
35 diff
(97.4 %id)
DA459751 tongue, tumor tissue TSTD2.b 1621 to 2186 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
CV325661 epid_tumor TSTD2.b 1630 to 2080 452 to 3     Submitted on the opposite strand 450/452
(99 %)
0 diff
(100 %id)
CK431028 eye, lacrimal gland TSTD2.b 1666 to 2282 1 to 617       617/617
(100 %)
0 diff
(100 %id)
DA733769   TSTD2.b 1725 to 2305 2 to 582   capped   581/591
(98 %)
3 diff
(99.5 %id)
AK056752 placenta TSTD2.b 1728 to 4709 1 to 2982   tiling clone, available from FLJ,   2982/2982
(100 %)
0 diff
(100 %id)
DA836446 placenta TSTD2.b 1729 to 2278 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BU430028 lymph TSTD2.b 1856 to 2231 1 to 376       376/376
(100 %)
4 diff
(99.0 %id)
TI_154151181   TSTD2.b 1862 to 2361 80 to 580       501/501
(100 %)
6 diff
(98.9 %id)
CA406929 adipose TSTD2.b 1904 to 2305 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
BF922902 nervous_tumor TSTD2.b 1977 to 2272 303 to 5     Submitted on the opposite strand 299/303
(98 %)
0 diff
(100 %id)
DA389889 thalamus TSTD2.b 1983 to 2561 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BF743395 breast TSTD2.b 2002 to 2466 1 to 464       464/464
(100 %)
7 diff
(98.5 %id)
BF743396 breast TSTD2.b 2002 to 2414 1 to 413       413/413
(100 %)
10 diff
(97.6 %id)
DA788725 brain TSTD2.b 2151 to 2738 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA272163 caudate nucleus TSTD2.b 2227 to 2788 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BQ305760 breast TSTD2.b 2244 to 2785 562 to 21       542/562
(96 %)
0 diff
(100 %id)
BI049790 placenta_normal TSTD2.b 2245 to 2644 1 to 401       401/401
(100 %)
8 diff
(98.1 %id)
BI049739 placenta_normal TSTD2.b 2287 to 2630 9 to 356       348/356
(97 %)
7 diff
(98.1 %id)
R57574   TSTD2.b 2311 to 2574 1 to 263       263/263
(100 %)
4 diff
(98.5 %id)
DA832276 placenta TSTD2.b 2337 to 2842 2 to 507   capped   506/569
(88 %)
2 diff
(99.7 %id)
BE299365 muscle, rhabdomyosarcoma TSTD2.b 2355 to 2939 16 to 600       585/600
(97 %)
6 diff
(99.0 %id)
DA078163 cerebellum TSTD2.b 2412 to 2976 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AA211221   TSTD2.b 2418 to 2766 1 to 348       348/348
(100 %)
4 diff
(98.9 %id)
AA337198 endometrium TSTD2.b 2481 to 2622 1 to 142       142/142
(100 %)
1 diff
(99.3 %id)
BG766505 melanotic melanoma, high MDR (cell line), skin TSTD2.b 2578 to 3213 172 to 827       761/831
(91 %)
51 diff
(93.9 %id)
CX761452 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass TSTD2.b 2682 to 3420 1 to 739       739/739
(100 %)
0 diff
(100 %id)
CX752032 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass TSTD2.b 2698 to 3405 1 to 697       697/859
(81 %)
21 diff
(97.6 %id)
CX871392 embryonic stem TSTD2.b 2899 to 3662 1 to 764       764/764
(100 %)
3 diff
(99.7 %id)
BQ322981 colon_est TSTD2.b 2907 to 3304 13 to 411       399/411
(97 %)
6 diff
(98.6 %id)
BF766098 colon_est TSTD2.b 2908 to 3322 1 to 416       416/416
(100 %)
6 diff
(98.6 %id)
AV692564 hepatocellular carcinoma TSTD2.b 2953 to 3584 1 to 622       622/625
(99 %)
6 diff
(99.1 %id)
BX357548 Placenta Cot 25-normalized TSTD2.b 2987 to 3357 1 to 373       373/661
(56 %)
15 diff
(97.8 %id)
AW369328 breast_normal TSTD2.b 3031 to 3652 11 to 629       619/638
(97 %)
6 diff
(99.1 %id)
CN298693 embryonic stem cells, cell lines H1, H7, andH9 TSTD2.b 3042 to 3737 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
AW991298 breast_normal TSTD2.b 3086 to 3253 1 to 166       166/166
(100 %)
3 diff
(98.2 %id)
AA195642 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 3187 to 3681 1 to 499       499/500
(99 %)
6 diff
(98.8 %id)
BQ954258 sciatic nerve TSTD2.b 3188 to 3982 1 to 808       808/918
(88 %)
20 diff
(97.9 %id)
AF131836   TSTD2.b 3235 to 4715 162 to 1641   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1480/1641
(90 %)
6 diff
(99.7 %id)
F12066 brain, total brain TSTD2.b 3250 to 3610 1 to 361       361/361
(100 %)
0 diff
(100 %id)
T66336 whole brain TSTD2.b 3275 to 3698 1 to 432       432/442
(97 %)
14 diff
(96.9 %id)
R96557 liver and spleen TSTD2.b 3292 to 3636 1 to 353       353/370
(95 %)
14 diff
(96.3 %id)
N92065 liver and spleen TSTD2.b 3292 to 3697 1 to 413       413/415
(99 %)
12 diff
(97.2 %id)
BG391984 embryonal carcinoma, cell line, testis TSTD2.b 3384 to 3680 1 to 299       299/299
(100 %)
7 diff
(97.7 %id)
BX371668 Placenta Cot 25-normalized TSTD2.b 3421 to 4032 608 to 1       608/903
(67 %)
11 diff
(98.8 %id)
DA695955   TSTD2.b 3469 to 4032 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB545738.
matches multiple genes
hippocampus TSTD2.b 3543 to 3985 443 to 1     also hits gene TMOD1 443/443
(100 %)
0 diff
(100 %id)
BM511510 insulinoma, Pancreas TSTD2.b 3550 to 4027 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
CK823888 insulinoma, Pancreas TSTD2.b 3550 to 4107 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
BM510672 insulinoma, Pancreas TSTD2.b 3551 to 4170 620 to 1       620/631
(98 %)
2 diff
(99.7 %id)
AA410680 ovarian tumor, ovary TSTD2.b 3552 to 4040 1 to 483       483/483
(100 %)
5 diff
(99.0 %id)
AA479854 ovarian tumor, ovary TSTD2.b 3554 to 3816 1 to 259       259/259
(100 %)
23 diff
(91.2 %id)
BM739853 Ascites, stomach TSTD2.b 3580 to 4026 1 to 447       447/447
(100 %)
8 diff
(98.3 %id)
BM755728 Ascites, stomach TSTD2.b 3580 to 3963 1 to 381       381/381
(100 %)
6 diff
(98.5 %id)
T29797 testis TSTD2.b 3622 to 3961 1 to 346       346/346
(100 %)
7 diff
(98.0 %id)
CU454746 epidermis TSTD2.b 3643 to 4413 13 to 783       771/783
(98 %)
5 diff
(99.4 %id)
BI962601 Islets of Langerhans, Pancreas TSTD2.b 3665 to 3872 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BI962789 Islets of Langerhans, Pancreas TSTD2.b 3665 to 4220 1 to 556     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 556/556
(100 %)
0 diff
(100 %id)
H15740 breast TSTD2.b 3708 to 4077 1 to 384       384/391
(98 %)
13 diff
(96.7 %id)
H50601 breast TSTD2.b 3708 to 4195 1 to 507       507/507
(100 %)
16 diff
(96.9 %id)
BF923749 nervous_tumor TSTD2.b 3726 to 4250 8 to 527       520/551
(94 %)
10 diff
(98.2 %id)
AL562460 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized TSTD2.b 3727 to 4665 937 to 1       937/937
(100 %)
52 diff
(94.5 %id)
AA232845 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 3772 to 4088 1 to 325       325/325
(100 %)
16 diff
(95.1 %id)
H00794 placenta TSTD2.b 3815 to 4161 1 to 356       356/411
(86 %)
12 diff
(97.1 %id)
BX357547 Placenta Cot 25-normalized TSTD2.b 3830 to 4687 846 to 1       846/887
(95 %)
10 diff
(98.9 %id)
AA026181 uterus TSTD2.b 3836 to 4000 1 to 165       165/165
(100 %)
0 diff
(100 %id)
BE703485 nervous_normal TSTD2.b 3847 to 4182 269 to 604       336/621
(54 %)
10 diff
(98.4 %id)
AL044511 testis TSTD2.b 3851 to 4366 1 to 516   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 516/516
(100 %)
0 diff
(100 %id)
AI951046 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary TSTD2.b 3927 to 4716 791 to 4       788/791
(99 %)
0 diff
(100 %id)
AI828284 adenocarcinoma, Pancreas TSTD2.b 3933 to 4710 776 to 1       776/776
(100 %)
18 diff
(97.7 %id)
BF969167 adrenal cortex carcinoma, cell line, adrenal gland TSTD2.b 3956 to 4626 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
AI583393 adenocarcinoma, Pancreas TSTD2.b 3992 to 4711 721 to 1       721/866
(83 %)
24 diff
(97.3 %id)
BU625565 cell lines, Enchondroma TSTD2.b 3995 to 4715 739 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 721/721
(100 %)
0 diff
(100 %id)
AA846589 parathyroid gland, parathyroid tumor TSTD2.b 4006 to 4709 720 to 14   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 707/707
(100 %)
14 diff
(98.1 %id)
AI684242 serous papillary carcinoma, high grade, 2pooled tumors, uterus TSTD2.b 4034 to 4709 678 to 1       678/678
(100 %)
3 diff
(99.6 %id)
AI860385 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors TSTD2.b 4037 to 4711 673 to 1       673/673
(100 %)
9 diff
(98.7 %id)
BU630127 cell lines, Chondrosarcoma TSTD2.b 4041 to 4709 687 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
AI745212 pooled TSTD2.b 4042 to 4708 679 to 14   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 666/670
(99 %)
6 diff
(99.2 %id)
BF890755 marrow TSTD2.b 4045 to 4206 1 to 162       162/162
(100 %)
3 diff
(98.2 %id)
BF890750 marrow TSTD2.b 4049 to 4206 1 to 158       158/158
(100 %)
1 diff
(99.4 %id)
BF895964 marrow TSTD2.b 4051 to 4250 26 to 226       201/229
(87 %)
4 diff
(98.3 %id)
AW058343 poorly differentiated adenocarcinoma withsignet ring cell features, stomach TSTD2.b 4053 to 4709 672 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 655/660
(99 %)
18 diff
(97.3 %id)
BQ050213 leiomyosarcoma, uterus TSTD2.b 4076 to 4714 38 to 678       641/1110
(57 %)
8 diff
(99.3 %id)
AA330142   TSTD2.b 4078 to 4463 1 to 395       395/395
(100 %)
12 diff
(97.0 %id)
AW966831   TSTD2.b 4079 to 4653 1 to 578       578/623
(92 %)
11 diff
(98.3 %id)
AI022245 liver and spleen TSTD2.b 4089 to 4709 621 to 1       621/621
(100 %)
13 diff
(98.0 %id)
AW451604   TSTD2.b 4109 to 4720 629 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
AI970589 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) TSTD2.b 4115 to 4711 609 to 11       599/609
(98 %)
0 diff
(100 %id)
AA001731 liver and spleen TSTD2.b 4120 to 4494 1 to 383   fully sequenced,   383/383
(100 %)
5 diff
(98.7 %id)
AA558423 germ cell tumor TSTD2.b 4152 to 4716 559 to 1       559/559
(100 %)
6 diff
(99.0 %id)
AA700429 liver and spleen TSTD2.b 4153 to 4709 558 to 1       558/558
(100 %)
13 diff
(97.7 %id)
AA972991 pooled TSTD2.b 4159 to 4715 560 to 1       560/560
(100 %)
18 diff
(96.8 %id)
DB313213 tongue, tumor tissue TSTD2.b 4164 to 4715 553 to 1       553/553
(100 %)
2 diff
(99.7 %id)
DB350088 trachea TSTD2.b 4166 to 4709 545 to 1       545/545
(100 %)
1 diff
(99.9 %id)
DB365750   TSTD2.b 4167 to 4709 541 to 1       541/545
(99 %)
8 diff
(98.6 %id)
AI082693 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4169 to 4710 543 to 1       543/551
(98 %)
19 diff
(96.6 %id)
FN122306 breast carcinoma TSTD2.b 4172 to 4263 1 to 92       92/94
(97 %)
1 diff
(99.0 %id)
AA916345 adenocarcinoma, colon TSTD2.b 4175 to 4714 540 to 1       540/540
(100 %)
13 diff
(97.6 %id)
DB324697   TSTD2.b 4192 to 4709 520 to 1       520/520
(100 %)
3 diff
(99.5 %id)
AI033908 parathyroid gland, parathyroid tumor TSTD2.b 4193 to 4711 516 to 1       516/516
(100 %)
41 diff
(92.1 %id)
DB328242 placenta TSTD2.b 4193 to 4709 518 to 1       518/518
(100 %)
1 diff
(99.9 %id)
AI350494 pooled germ cell tumors TSTD2.b 4194 to 4709 516 to 1       516/516
(100 %)
8 diff
(98.5 %id)
AW591000 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus TSTD2.b 4199 to 4709 511 to 1       511/511
(100 %)
9 diff
(98.3 %id)
AI015189   TSTD2.b 4215 to 4713 500 to 3       498/504
(98 %)
0 diff
(100 %id)
AA746193 Kidney TSTD2.b 4218 to 4713 497 to 2       496/497
(99 %)
0 diff
(100 %id)
AA916344 adenocarcinoma, colon TSTD2.b 4218 to 4714 489 to 1       489/489
(100 %)
11 diff
(97.8 %id)
AA773651 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4219 to 4623 1 to 405       405/405
(100 %)
0 diff
(100 %id)
AI831428 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) TSTD2.b 4222 to 4709 501 to 16   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 486/497
(97 %)
11 diff
(97.8 %id)
AA832196 germinal center B cell TSTD2.b 4223 to 4718 498 to 1       498/498
(100 %)
16 diff
(96.8 %id)
H00693 placenta TSTD2.b 4228 to 4709 490 to 1       490/494
(99 %)
4 diff
(99.2 %id)
AA233756 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4228 to 4708 480 to 1       480/480
(100 %)
19 diff
(96.1 %id)
H50602 breast TSTD2.b 4233 to 4708 498 to 10       489/504
(97 %)
0 diff
(100 %id)
AA479728 ovarian tumor, ovary TSTD2.b 4236 to 4716 489 to 8       482/496
(97 %)
0 diff
(100 %id)
DB378383 placenta TSTD2.b 4236 to 4709 473 to 1       473/477
(99 %)
12 diff
(97.5 %id)
AI281305 adenocarcinoma, colon TSTD2.b 4237 to 4716 487 to 8       480/522
(91 %)
0 diff
(100 %id)
BI789270 Islets of Langerhans, Pancreas TSTD2.b 4238 to 4709 493 to 22   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 472/472
(100 %)
2 diff
(99.6 %id)
AI285037 adenocarcinoma, colon TSTD2.b 4240 to 4716 484 to 8       477/484
(98 %)
0 diff
(100 %id)
AI362303 brain, glioblastoma (pooled) TSTD2.b 4241 to 4709 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AA195643 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4248 to 4716 477 to 5       473/479
(98 %)
0 diff
(100 %id)
AI080661 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4257 to 4710 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AA634502   TSTD2.b 4261 to 4712 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AI570310 poorly differentiated adenocarcinoma withsignet ring cell features, stomach TSTD2.b 4264 to 4709 463 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 446/446
(100 %)
3 diff
(99.4 %id)
AI799180 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus TSTD2.b 4264 to 4709 444 to 1       444/444
(100 %)
5 diff
(98.9 %id)
AW662001 pooled TSTD2.b 4266 to 4712 453 to 1       453/453
(100 %)
7 diff
(98.5 %id)
AA252215 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4271 to 4711 441 to 1       441/441
(100 %)
0 diff
(100 %id)
BI494941 cochlea, ear TSTD2.b 4273 to 4702 430 to 1       430/430
(100 %)
28 diff
(93.5 %id)
AA026182 uterus TSTD2.b 4275 to 4685 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
AI468452 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4275 to 4709 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
BM930748 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid TSTD2.b 4275 to 4709 1 to 435   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 435/435
(100 %)
1 diff
(99.8 %id)
N68852 liver and spleen TSTD2.b 4281 to 4709 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
AA115226 uterus TSTD2.b 4292 to 4709 421 to 1       421/421
(100 %)
3 diff
(99.3 %id)
T66285 whole brain TSTD2.b 4312 to 4395 84 to 1       84/84
(100 %)
4 diff
(95.3 %id)
AA211123   TSTD2.b 4313 to 4711 407 to 1       407/410
(99 %)
10 diff
(97.6 %id)
AA233256 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TSTD2.b 4324 to 4710 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA235388 ovarian tumor, ovary TSTD2.b 4333 to 4715 382 to 1       382/385
(99 %)
7 diff
(98.2 %id)
AL044512 testis TSTD2.b 4336 to 4709 387 to 13   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 375/375
(100 %)
1 diff
(99.8 %id)
AA844616 parathyroid gland, parathyroid tumor TSTD2.b 4340 to 4713 368 to 3       366/368
(99 %)
0 diff
(100 %id)
R38987.
matches multiple genes
whole brain TSTD2.b 4349 to 4715 379 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base), also hits gene sparjee 368/368
(100 %)
5 diff
(98.7 %id)
AW768402 lymph node, lymphoma, follicular mixed small and largecell TSTD2.b 4356 to 4709 356 to 1       356/356
(100 %)
5 diff
(98.6 %id)
H15741 breast TSTD2.b 4367 to 4709 355 to 1       355/372
(95 %)
24 diff
(93.6 %id)
AW024658 Kidney TSTD2.b 4370 to 4712 344 to 1       344/344
(100 %)
1 diff
(99.8 %id)
AA652384 normal prostate, Prostate TSTD2.b 4391 to 4709 318 to 1       318/318
(100 %)
28 diff
(91.2 %id)
F09707 brain, total brain TSTD2.b 4392 to 4709 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AI567185 serous papillary carcinoma, high grade, 2pooled tumors, uterus TSTD2.b 4410 to 4709 335 to 36   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 300/332
(90 %)
25 diff
(92.5 %id)
AA627077 normal prostate, Prostate TSTD2.b 4423 to 4709 287 to 1       287/287
(100 %)
0 diff
(100 %id)
AA001931 liver and spleen TSTD2.b 4464 to 4710 254 to 1   fully sequenced,   254/254
(100 %)
0 diff
(100 %id)
BM685270 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid TSTD2.b 4473 to 4709 255 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 237/237
(100 %)
0 diff
(100 %id)
EC549774 Prostate TSTD2.b 4488 to 4577 1 to 88       88/88
(100 %)
1 diff
(98.9 %id)
GD142982   TSTD2.b 4510 to 4713 1 to 204       204/339
(60 %)
3 diff
(99.2 %id)
R96512 liver and spleen TSTD2.b 4583 to 4710 128 to 1       128/128
(100 %)
0 diff
(100 %id)
DB256394 uterus TSTD2.c 1 to 564 6 to 569   tiling clone, capped   568/568
(100 %)
3 diff
(99.5 %id)
DB351420 uterus TSTD2.c 3609 to 4135 528 to 1   tiling clone,   528/528
(100 %)
3 diff
(99.5 %id)
BE219525 carcinoid, lung TSTD2.d 1 to 468 468 to 1   tiling clone,   468/468
(100 %)
0 diff
(100 %id)
BE219750 carcinoid, lung TSTD2.d 14 to 468 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AW872392 carcinoid, lung TSTD2.d 18 to 468 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BX500922 Liver TSTD2.d 431 to 1095 1 to 664   tiling clone,   664/664
(100 %)
1 diff
(99.9 %id)
AK122809 uterus, tumor tissue TSTD2.d 640 to 4205 1 to 3566   tiling clone, available from FLJ,   3566/3566
(100 %)
3 diff
(100.0 %id)
DB244232 uterus, tumor tissue TSTD2.d 641 to 1197 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA216629 brain TSTD2.d 673 to 1209 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
AL602631 human skeletal muscle TSTD2.d 867 to 1467 601 to 1     Submitted on the opposite strand 601/601
(100 %)
2 diff
(99.7 %id)
DR003204 fetal brain TSTD2.d 1329 to 1940 1 to 612       612/612
(100 %)
5 diff
(99.2 %id)
DB281284 uterus TSTD2.d 1362 to 1912 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CN293817 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 TSTD2.d 2448 to 3074 1 to 627   tiling clone,   627/627
(100 %)
5 diff
(99.3 %id)
DA117291 cerebellum TSTD2.d 3187 to 3732 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA126846 cerebellum TSTD2.d 3187 to 3765 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB063300 testis TSTD2.d 3234 to 3783 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB350675 uterus, tumor tissue TSTD2.d 3700 to 4205 506 to 1       506/506
(100 %)
1 diff
(99.9 %id)
BF872714 lung_tumor TSTD2.d 3794 to 4109 316 to 1     Submitted on the opposite strand 316/320
(98 %)
2 diff
(99.4 %id)
AW149071 Kidney, renal cell tumor TSTD2.d 4015 to 4205 191 to 1   tiling clone,   191/191
(100 %)
0 diff
(100 %id)
GD142820   TSTD2.d 4022 to 4205 1 to 183   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 183/183
(100 %)
4 diff
(97.9 %id)
BC022958 Brain, anaplastic oligodendroglioma with1p/19q loss TSTD2.d 4065 to 7139 1 to 3075   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 3075/3075
(100 %)
0 diff
(100 %id)
BG818819 anaplastic oligodendroglioma with 1p/19qloss, brain TSTD2.d 4066 to 4887 1 to 827   available from MGC,   827/832
(99 %)
19 diff
(97.8 %id)
AV659376 corresponding non cancerous liver tissue TSTD2.d 4296 to 4714 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
CV029840 mixed TSTD2.d 4431 to 4598 1 to 168       168/170
(98 %)
2 diff
(98.9 %id)
BQ723588 sympathetic trunk TSTD2.e 1 to 961 1 to 965 G89X K94X K122Q V127G D129* tiling clone,   965/965
(100 %)
20 diff
(98.0 %id)
AF258575   TSTD2.f 1 to 1605 1 to 1605 exact tiling clone, AAA   1605/1605
(100 %)
2 diff
(99.9 %id)
DA414980 thalamus TSTD2.g 1 to 551 2 to 552   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA227797 brain TSTD2.h 1 to 576 2 to 578   tiling clone, capped   577/577
(100 %)
3 diff
(99.5 %id)
AA477609 ovarian tumor, ovary TSTD2.h 338 to 921 1 to 584 exact tiling clone,   584/584
(100 %)
0 diff
(100 %id)
AI820922 ovarian tumor, ovary TSTD2.h 338 to 803 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
DA214702 brain TSTD2.i 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
AA252842 germinal center B cell TSTD2.i 173 to 551 382 to 3   tiling clone, Submitted on the opposite strand 380/382
(99 %)
1 diff
(99.8 %id)
BF673393 Prostate TSTD2.j 1 to 669 1 to 666 C15A R16E N17T F18S Y19M ... tiling clone,   666/934
(71 %)
30 diff
(96.8 %id)
DA756482   TSTD2.k 1 to 413 2 to 414   tiling clone, capped   413/415
(99 %)
2 diff
(99.6 %id)
DA103005 cerebellum TSTD2.k 3 to 557 2 to 557   tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
CF138261 lymph TSTD2.k 434 to 1018 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
TI_154168140   TSTD2.k 438 to 1217 88 to 880   tiling clone,   791/818
(96 %)
24 diff
(97.1 %id)
BG719872 testis TSTD2.l 1 to 709 1 to 716   tiling clone,   716/716
(100 %)
24 diff
(96.7 %id)
DA185522 amygdala TSTD2.l 220 to 778 2 to 561   tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
AI684559 pooled TSTD2.l 673 to 1172 507 to 8 exact tiling clone,   500/507
(98 %)
0 diff
(100 %id)
CR740467 pooled TSTD2.m-u 1 to 340 340 to 1 exact tiling clone, Submitted on the opposite strand 340/346
(98 %)
0 diff
(100 %id)
DA300414 hippocampus TSTD2.m-u 139 to 726 2 to 589   tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
BX489640   TSTD2.n 1 to 647 1 to 647 K8Q P13Q T14Q R16G S17V ... tiling clone,   647/647
(100 %)
10 diff
(98.5 %id)
DB067720 testis TSTD2.o 1 to 571 2 to 572 exact tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DA520152 brain TSTD2.p 1 to 563 2 to 564 C22R tiling clone, capped   563/563
(100 %)
3 diff
(99.5 %id)
AI821673 ovarian tumor, ovary TSTD2.q-u 1 to 496 496 to 1 exact tiling clone,   496/496
(100 %)
0 diff
(100 %id)
BE645010 pooled TSTD2.q-u 39 to 496 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AA477484 ovarian tumor, ovary TSTD2.q-u 181 to 496 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
DA189200 amygdala TSTD2.r 1 to 473 2 to 475 G15W S16K R17S L18V S19I ... tiling clone, capped   474/474
(100 %)
1 diff
(99.8 %id)
DB447273 testis TSTD2.r 31 to 452 1 to 424   tiling clone,   424/424
(100 %)
4 diff
(99.1 %id)
FN161825 breast carcinoma TSTD2.r 301 to 401 105 to 1     Submitted on the opposite strand 105/105
(100 %)
3 diff
(97.2 %id)
AK094043 uterus Gene TSTD2, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AX748426   Gene TSTD2, variant not shown         Suspected internal deletion, this clone was ignored    
DA509226 brain Gene TSTD2, variant not shown       capped Suspected internal deletion, this clone was ignored    
AV686037 hepatocellular carcinoma Gene TSTD2, variant not shown         Suspected internal deletion, this clone was ignored    
DA932913 Spleen Gene TSTD2, variant not shown       capped This clone was ignored    
DB332621 Spleen Gene TSTD2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o, .p, .q-u, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C